Regis Technologies, Inc.

Morton Grove, IL 60053

SBIR Award Summary

Total Number of Awards 8
Total Value of Awards $0.0
First Award Date 02/01/86
Most Recent Award Date 09/10/98

Key Personnel

Last Name Name Awards Contact
Perry John A Perry 3
Glunz Louis J Glunz 3
Welch Christopher J Welch 2

8 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/10/98 - 03/09/99

The current selection of commercial chiral stationary phases (CSPs) for large scale chromatographic separations are quite limited, and most have been developed as general purpose CSPs rather than the best CSP for a particular separation. While new CSPs can be designed, the development time is often too long ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/94 - 04/30/95

DESCRIPTION: (Adapted from the applicant's abstract) Immobilized Artificial Membrane (IAM) technology involves covalently bonding membrane lipids to solid surfaces through the lipid alkyl chains. For Phase II of the project, the applicants will expand the selectivity of IAM surfaces by preparing at least 9 different IAMs. The new IAM surface...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/93 - 01/31/94

A new family of enantioselective dirhodiumn(II) catalysts have been developed by Professor Michael P. Doyle at Trinity University using a rational approach employing molecular modeling and molecular orbital calculations. These catalysts show an extraordinary ability to enantioselectively catalyze a number of different organic reactions, allowin...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/07/93 - 04/30/94

DESCRIPTION: (Adapted from the applicant's abstract) Immobilized Artificial Membrane (IAM) technology involves covalently bonding membrane lipids to solid surfaces through the lipid alkyl chains. For Phase II of the project, the applicants will expand the selectivity of IAM surfaces by preparing at least 9 different IAMs. The new IAM surface...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/01/92 - 07/31/92

Membrane protein studies are severely limited by lack of efficient methods for their purification. IAM surfaces have recently been discovered and are extremely effective at purifying functional membranes proteins. Since IAM surfaces are prepared by covalently bonding membrane-forming-lipids to silica, the IAM chromatographic surface emulates t...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/01/89 - 02/28/90

Drugs are now determined in serum-hundreds of thousands of samples per year in the United States alone--by high pressure liquid chromatography (HPLC). Protein must first be removed from the serum. Otherwise the HPLC columns are quickly ruined. Internal- surface reversed-phase (ISRP) HPLC columns afford such determinations without requiring th...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/01/88 - 02/28/89

Drugs are now determined in serum-hundreds of thousands of samples per year in the United States alone--by high pressure liquid chromatography (HPLC). Protein must first be removed from the serum. Otherwise the HPLC columns are quickly ruined. Internal- surface reversed-phase (ISRP) HPLC columns afford such determinations without requiring th...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/01/86 - 07/31/86

Hundreds of thousands of serum and plasma samples are yearly analyzed. When done by high pressure liquid chromatography (HPLC), protein must first be removed from each. Otherwise the HPLC columns are quickly ruined. Dr. T. C. Pinkerton has invented an answer to this problem: the Internal Surface Reverse Phase (ISRP). An HPLC column that cont...